---
figid: PMC3253915__nihms-328472-f0002
figtitle: Innovative Therapy for Classic Galactosemia - Tale of Two HTS
organisms:
- NA
pmcid: PMC3253915
filename: nihms-328472-f0002.jpg
figlink: /pmc/articles/PMC3253915/figure/F2/
number: F2
caption: 'Gal-1P (an intermediate) and galactitol (a by-product) of the blocked galactose
  metabolic pathway interfere inositol turnover and inositol entry by inhibiting IMPase
  and SMIT, respectively. This could potentially decrease cellular PIP2 content and
  adversely affect normal AKT function. Blockage of galactose metabolism has also
  been shown to up-regulate ARHI gene expression [], which negatively regulate AKT
  activity in the cells. (Abbreviations: PIP2: phosphatidylinositol-4,5-biphosphate;
  IP3: inositol-1,4,5-triphosphate; IP2: inositol bisphosphate; IP1: inositol monophosphate;
  PIP3: phosphatidylinositol-3,4,5-triphosphate; SMIT1: Na+/myo-inositol transporter;
  IMPase: inositol monophosphatase; P13K: phosphatidylinositol 3-kinase; GPCR: G-protein
  coupled receptor. L: ligand for GPCR; EGF: epidermal growth factor; EGFR: epidermal
  growth factor receptor; PTEN: phosphatase and tensin homolog; ARHI: aplysia ras
  homolog I.)'
papertitle: Innovative Therapy for Classic Galactosemia - Tale of Two HTS.
reftext: M Tang, et al. Mol Genet Metab. ;105(1):44-55.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9586458
figid_alias: PMC3253915__F2
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC3253915__F2
ndex: ab5ec082-dee2-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3253915__nihms-328472-f0002.html
  '@type': Dataset
  description: 'Gal-1P (an intermediate) and galactitol (a by-product) of the blocked
    galactose metabolic pathway interfere inositol turnover and inositol entry by
    inhibiting IMPase and SMIT, respectively. This could potentially decrease cellular
    PIP2 content and adversely affect normal AKT function. Blockage of galactose metabolism
    has also been shown to up-regulate ARHI gene expression [], which negatively regulate
    AKT activity in the cells. (Abbreviations: PIP2: phosphatidylinositol-4,5-biphosphate;
    IP3: inositol-1,4,5-triphosphate; IP2: inositol bisphosphate; IP1: inositol monophosphate;
    PIP3: phosphatidylinositol-3,4,5-triphosphate; SMIT1: Na+/myo-inositol transporter;
    IMPase: inositol monophosphatase; P13K: phosphatidylinositol 3-kinase; GPCR: G-protein
    coupled receptor. L: ligand for GPCR; EGF: epidermal growth factor; EGFR: epidermal
    growth factor receptor; PTEN: phosphatase and tensin homolog; ARHI: aplysia ras
    homolog I.)'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Egfr
  - Oamb
  - norpA
  - sl
  - Plc21C
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - Pten
  - Galk
  - Galt
  - beta4GalT7
  - EGF
  - EGFR
  - FZD4
  - NMUR1
  - LPAR3
  - LGR6
  - MRGPRX3
  - MRGPRX4
  - GPR151
  - OXER1
  - GPRC6A
  - MRGPRX1
  - VN1R17P
  - GPR166P
  - GRM1
  - GRM2
  - GRM3
  - GRM4
  - GRM5
  - GRM6
  - GRM7
  - GRM8
  - CASR
  - GABBR1
  - GABBR2
  - GPR156
  - GPR158
  - GPR179
  - GPRC5A
  - GPRC5B
  - GPRC5C
  - GPRC5D
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - DIRAS3
  - PTEN
  - IKBKG
  - GALK1
  - LGALS1
  - GALT
  - B3GLCT
  - Galactitol
  - Galactose
  - Glucose
  - phosphate
  - UDP-Cialactose
  - Cancer
---
